News & Updates
Filter by Specialty:

Ketogenic trials with Parkinson’s disease-specific outcomes lacking
The ketogenic diet, as well as ketogenic agents, has been shown to be a promising therapeutic regimen for Parkinson’s disease (PD) in animals, but research on humans is highly heterogenous and lacking PD-specific outcomes, according to a study.
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022
Pandemic-caused treatment delays for cancer may aggravate psychological distress
Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.
Pandemic-caused treatment delays for cancer may aggravate psychological distress
18 Jun 2022
Dulaglutide: A new horizon for T2D treatment in kids
A once-weekly subcutaneous dose of the GLP-1* receptor agonist dulaglutide successfully controlled glycaemic levels in youths with type 2 diabetes (T2D) being treated with lifestyle modification with or without metformin or insulin, results of the multinational, phase III AWARD-PEDS** study showed.